MYTEF yields 4.22% · JNJ yields 2.13%● Live data
📍 MYTEF pulled ahead of the other in Year 1
Combined, MYTEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MYTEF + JNJ for your $10,000?
Telekom Malaysia Berhad engages in the establishment, maintenance, and provision of telecommunications and related services in Malaysia and internationally. It operates through unifi, TM ONE, TM WHOLESALE, and Shared Services/Others segments. The company offers a suite of communication services and solutions in fixed telephony and broadband, mobility, content, Wi-Fi, information and communications technology (ICT), cloud, data center, and smart services. It also provides network connectivity and bandwidth; project management; managed network, and value-added telecommunication and information technology services; cloud consumption; and transmission of voice and data services, as well as develops and sells software products. In addition, the company engages in the provision of research and development activities in the areas of communications, hi-tech applications, and products and services in related business; management of customer care services; trading of customer premises telecommunication equipment; property development activities; and content and application development for internet services. Further, it provides printed and online telephone directories; broadband network infrastructure facilities and services; and network system integration, network centric, integrated security management system, and fleet management services, as well as training and related services. Additionally, the company builds, provides, and manages smart buildings, which include smart tenant services for the building owners, operators, residents, and visitors; international telecommunications; ICT system security. It serves approximately 2.78 million fixed broadband customers. The company was founded in 1946 and is headquartered in Kuala Lumpur, Malaysia.
Full MYTEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.